Paul Sekhri, eGenesis CEO
George Church spinoff swallows a key manufacturing partner as it preps CRISPR-edited pig organs for animal testing
Researching, cloning and breeding gene-edited pigs are core to eGenesis’ audacious mission to grow organs that can be xenotransplanted into humans. But perhaps unsurprisingly …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
